Susceptibility weighted imaging (SWI).

Susceptibility differences between tissues can be utilized as a new type of contrast in MRI that is different from spin density, T1-, or T2-weighted imaging. Signals from substances with different magnetic susceptibilities compared to their neighboring tissue will become out of phase with these tissues at sufficiently long echo times (TEs). Thus, phase imaging offers a means of enhancing contrast in MRI. Specifically, the phase images themselves can provide excellent contrast between gray matter (GM) and white matter (WM), iron-laden tissues, venous blood vessels, and other tissues with susceptibilities that are different from the background tissue. Also, for the first time, projection phase images are shown to demonstrate tissue (vessel) continuity. In this work, the best approach for combining magnitude and phase images is discussed. The phase images are high-pass-filtered and then transformed to a special phase mask that varies in amplitude between zero and unity. This mask is multiplied a few times into the original magnitude image to create enhanced contrast between tissues with different susceptibilities. For this reason, this method is referred to as susceptibility-weighted imaging (SWI). Mathematical arguments are presented to determine the number of phase mask multiplications that should take place. Examples are given for enhancing GM/WM contrast and water/fat contrast, identifying brain iron, and visualizing veins in the brain.

[1]  S. Ogawa,et al.  Oxygenation‐sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields , 1990, Magnetic resonance in medicine.

[2]  Rudolf Stollberger,et al.  Automated unwrapping of MR phase images applied to BOLD MR‐venography at 3 Tesla , 2003, Journal of magnetic resonance imaging : JMRI.

[3]  J W Langston,et al.  The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. , 1999, Magnetic resonance imaging.

[4]  S. Ogawa,et al.  Magnetic resonance imaging of blood vessels at high fields: In vivo and in vitro measurements and image simulation , 1990, Magnetic resonance in medicine.

[5]  J R Reichenbach,et al.  High-Resolution MR Venography at 3.0 Tesla , 2000, Journal of computer assisted tomography.

[6]  W. Lin,et al.  MR high-resolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions. , 1999, AJNR. American journal of neuroradiology.

[7]  Yu-Chung N. Cheng,et al.  Susceptibility weighted imaging (SWI) , 2004, Zeitschrift fur medizinische Physik.

[8]  D. Tank,et al.  Brain magnetic resonance imaging with contrast dependent on blood oxygenation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[9]  L R Schad,et al.  Improved target volume characterization in stereotactic treatment planning of brain lesions by using high‐resolution BOLD MR‐venography , 2001, NMR in biomedicine.

[10]  E Mark Haacke,et al.  Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results. , 2003, Radiology.

[11]  J R Reichenbach,et al.  Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. , 1997, Radiology.

[12]  W. T. Dixon.  Simple proton spectroscopic imaging. , 1984, Radiology.

[13]  N. Yamada,et al.  Intracranial calcification on gradient-echo phase image: depiction of diamagnetic susceptibility. , 1996, Radiology.

[14]  E M Haacke,et al.  Artery and vein separation using susceptibility‐dependent phase in contrast‐enhanced MRA , 2000, Journal of magnetic resonance imaging : JMRI.

[15]  E. Haacke,et al.  High‐resolution BOLD venographic imaging: a window into brain function , 2001, NMR in biomedicine.

[16]  L R Schad,et al.  Comparison of functional MR-venography and EPI-BOLD fMRI at 1.5 T. , 1998, Magnetic resonance imaging.

[17]  R. Weisskoff,et al.  MRI susceptometry: Image‐based measurement of absolute susceptibility of MR contrast agents and human blood , 1992, Magnetic resonance in medicine.

[18]  J Debus,et al.  [High resolution MR-venography of cerebral arteriovenous malformations]. , 1999, Der Radiologe.

[19]  D. Firmin,et al.  Measurement of Flow with NMR Imaging Using a Gradient Pulse and Phase Difference Technique , 1984, Journal of computer assisted tomography.

[20]  J. R. Reichenbach,et al.  High-resolution blood oxygen-level dependent MR venography (HRBV): a new technique , 2001, Neuroradiology.

[21]  Markus Barth,et al.  High-Resolution Three-Dimensional Contrast-Enhanced Blood Oxygenation Level-Dependent Magnetic Resonance Venography of Brain Tumors at 3 Tesla: First Clinical Experience and Comparison with 1.5 Tesla , 2003, Investigative radiology.

[22]  H. An,et al.  Improving high‐resolution MR bold venographic imaging using a T1 reducing contrast agent , 1999, Journal of magnetic resonance imaging : JMRI.

[23]  Weili Lin,et al.  In vivo validation of the bold mechanism: A review of signal changes in gradient echo functional MRI in the presence of flow , 1995, Int. J. Imaging Syst. Technol..

[24]  Petra Schmalbrock,et al.  Enhanced gray and white matter contrast of phase susceptibility‐weighted images in ultra‐high‐field magnetic resonance imaging , 2003, Journal of magnetic resonance imaging : JMRI.

[25]  F Barkhof,et al.  MR venography of multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.

[26]  E. Haacke,et al.  Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.

[27]  Song Lai,et al.  Spatial Selectivity of BOLD Contrast: Effects In and Around Draining Veins , 2000 .